NNNN
Anbio Biotechnology
6.10$
-3.3%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | +184.0% | +13.3% | +19.7% | +59.8% | |
| – | +183.6% | +13.0% | +17.7% | +63.2% | |
| – | +69.9% | +36.4% | +21.4% | -34.0% | |
| – | +107.3% | +11.8% | +21.4% | +1.2% | |
| – | -99.5% | +52,537.8% | -43.5% | +243.4% | |
| – | – | -100.0% | – | – | |
| – | -40.7% | -29.6% | +74.2% | -94.9% | |
| – | -40.7% | -29.6% | +74.2% | -94.9% | |
| – | -25.5% | -41.3% | +96.5% | -100.0% | |
| – | +394.8% | +18.1% | +16.0% | +75.4% | |
| – | +394.8% | +18.0% | +16.0% | +37.3% | |
| – | +43.9% | +30.5% | -77.5% | +3.8% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.